Context Therapeutics Inc.
corporate_fare Company Profile
Context Therapeutics Inc. (NASDAQ:CNTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for CNTX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Context Therapeutics Reports Positive Interim Phase 1a Data for CTIM-76 and Extends Cash Runway
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$36.12M
Diluted EPS
-$0.38
Op. Cash Flow
-$26.39M
Free Cash Flow
-$26.42M
Operating Income
-$39.7M
Cash & Equivalents
$66M
Debt / Equity
0.00×
Shares Outstanding
91.88M sh
Source: 10-K · filed 2026-03-23 · accession 0001628280-26-020498
show_chartPrice Chart
Loading chart...
feed CNTX - Filings & News (Page 2)
CNTX
Jan 08, 2026, 7:43 AM EST
Price at Filing:
$1.74
Real-time Price:
$0.160
Change:
-$1.58 (-91%)
Market Cap:
$14.701M